Similar Search Results

Advanced therapy medicinal products and health technology assessment principles and practices for value-based and sustainable healthcare

Jönsson, Bengt; Hampson, Grace; Michaels, Jonathan; … - In: The European journal of health economics : HEPAC ; … 20 (2019) 3, pp. 427-438

Persistent link: https://www.econbiz.de/10012005044

Value-based differential pricing : efficient prices for drugs in a global context

Danzon, Patricia Munch; Towse, Adrian; Mestre … - In: Health economics 24 (2015) 3, pp. 294-301

Persistent link: https://www.econbiz.de/10011317796

European Union pharmaceutical markets : a case for differential pricing?

Towse, Adrian; Pistollato, Michele; Mestre Ferrándiz, Jorge - In: International journal of the economics of business 22 (2015) 2, pp. 263-275

Persistent link: https://www.econbiz.de/10011405972

Differential pricing for pharmaceuticals : reconciling access, R&D and pants

Danzon, Patricia Munch; Towse, Adrian - In: International journal of health care finance and economics 3 (2003) 3, pp. 183-205

Persistent link: https://www.econbiz.de/10001860153

Is it time to reconsider the role of patient co-payments for pharmaceuticals in Europe?

Drummond, Michael F.; Towse, Adrian - In: The European journal of health economics : HEPAC ; … 13 (2012) 1, pp. 1-5

Persistent link: https://www.econbiz.de/10009491176

Orphan drugs policies : a suitable case for treatment ; editorial

Drummond, Michael F.; Towse, Adrian - In: The European journal of health economics : HEPAC ; … 15 (2014) 4, pp. 335-340

Persistent link: https://www.econbiz.de/10010360871

The efficient use of pharmaceuticals : does Europe have any lessons for a Medicare drug benefit?

Towse, Adrian - In: Health affairs : at the intersection of health, health … 22 (2003) 3, pp. 42-45

Persistent link: https://www.econbiz.de/10001767925

If it ain't broke, don't price fix it : the OFT and the PPRS

Towse, Adrian - In: Health economics 16 (2007) 7, pp. 653-665

Persistent link: https://www.econbiz.de/10003516263

Theory and implementation of differential pricing for pharmaceuticals

Danzon, Patricia Munch; Towse, Adrian - In: International public goods and transfer of technology …, (pp. 457-492). 2005

Persistent link: https://www.econbiz.de/10003414413

Comparative and Relative Effectiveness : A Challenge for Health Systems, Regulators, or Pharmaceutical Companies?

Towse, Adrian - 2015

Looking at how well drugs work in routine clinical practice, rather than only in experimental randomised controlled clinical trials (RCTs), is increasingly seen as essential for a proper assessment of both net benefit (health gain minus harm and value (net benefit minus net cost). Establishing...

Persistent link: https://www.econbiz.de/10013018440